Injecting botulinum toxin type A into areas where scarring can occur from facelift surgery yields noticeable improvements in the quantitative evaluation and subjective appreciation of postsurgical scars, according to a small study published in the American Journal of Cosmetic Surgery.
Read more at Dermatology Times >>